*** Welcome to piglix ***

Gamma-hydroxybutyrate

γ-Hydroxybutyric acid
4-Hydroxybutansäure - 4-Hydroxybutanoic acid.svg
GHB-3D-balls.png
Clinical data
Pregnancy
category
  • B
Routes of
administration
Usually by mouth; intravenous
ATC code N01AX11 (WHO) N07XX04 (WHO)
Legal status
Legal status
Pharmacokinetic data
Bioavailability 25% (oral)
Metabolism 95%, mainly liver, also in blood and tissues
Onset of action Within 5–15 min
Biological half-life 30–60 minutes
Excretion 5%, kidney
Identifiers
Synonyms γ-Hydroxybutyric acid
γ-Hydroxybutyrate
GHB
CAS Number 591-81-1 YesY
PubChem (CID) 3037032
IUPHAR/BPS 4711
DrugBank DB01440 YesY
ChemSpider 9984 YesY
UNII 30IW36W5B2 YesY
KEGG C00989 YesY
ChEBI CHEBI:30830 YesY
ChEMBL CHEMBL1342 YesY
Chemical and physical data
Formula C4H8O3
Molar mass 104.10 g/mol (GHB)
126.09 g/mol (sodium salt)
142.19 g/mol (potassium salt)
3D model (Jmol) Interactive image
  

γ-Hydroxybutyric acid (GHB), also known as 4-hydroxybutanoic acid, is a naturally occurring neurotransmitter and a psychoactive drug. It is a precursor to GABA, glutamate, and glycine in certain brain areas, and it acts on the GHB receptor and it is a weak agonist at the GABAB receptor.

GHB has been used in a medical setting as a general anesthetic and as a treatment for cataplexy, narcolepsy and alcoholism. It is also used illegally as an intoxicant, to try to increase athletic performance, and as a date rape drug. It is commonly used in the form of a salt, such as sodium γ-hydroxybutyrate (Na.GHB, sodium oxybate, or Xyrem) or potassium γ-hydroxybutyrate (K.GHB, potassium oxybate).

GHB is also produced as a result of fermentation, and is found in small quantities in some beers and wines, beef and small citrus fruits.

Succinic semialdehyde dehydrogenase deficiency is a disease that causes GHB to accumulate in the blood.

The only common medical use for GHB today are in the treatment of narcolepsy and more rarely alcoholism. It is sometimes used off-label for the treatment of fibromyalgia.

GHB is the active ingredient in the prescription medication sodium oxybate (Xyrem). Sodium oxybate is approved by the U.S. Food and Drug Administration (FDA) for the treatment of cataplexy associated with narcolepsy and excessive daytime sleepiness (EDS) associated with narcolepsy.


...
Wikipedia

...